Key Data Points

Primary metrics and data points about Epizyme.
Current Price: $20.48
Prev Close: $20.10
Open: $19.99
Bid: $20.47
Ask: $20.51
Day's Range: $19.78 - $20.56
52wk Range: $16.51 - $40.98
Volume: 53,198
Avg Vol 349,401
Market Cap: $700M
P/E (ttm): 502.50
EPS (ttm): $0.04
Div & Yield: $0.00 (0.0%)

Business Summary

Industry, sector and description for Epizyme.

Epizyme Inc is a clinical stage biopharmaceutical company that discovers develops and plans to commercialize personalized therapeutics for patients with genetically defined cancers.

  • Exchange: NASDAQ

Stock Charting

EPZM vs. SPY | 2 Year Performance
Sponsored by

Company Rating

What our community thinks about Epizyme.
CAPS Rating 3 out of 5
 
32 Outperform
5 Underperform
CAPS All Stars
 
15 Outperform
3 Underperform

Powered by Motley Fool CAPS


More Details about Epizyme

Primary metrics and data points about Epizyme.

Company Photos

Powered by